vs

Side-by-side financial comparison of BYLINE BANCORP, INC. (BY) and OPKO HEALTH, INC. (OPK). Click either name above to swap in a different company.

OPKO HEALTH, INC. is the larger business by last-quarter revenue ($148.5M vs $112.4M, roughly 1.3× BYLINE BANCORP, INC.). BYLINE BANCORP, INC. runs the higher net margin — 33.4% vs -21.1%, a 54.5% gap on every dollar of revenue. On growth, BYLINE BANCORP, INC. posted the faster year-over-year revenue change (9.0% vs -19.2%). Over the past eight quarters, BYLINE BANCORP, INC.'s revenue compounded faster (6.4% CAGR vs -7.5%).

Byline Bank is a bank headquartered in Chicago, Illinois, United States. It is the primary subsidiary of Byline Bancorp, Inc., a bank holding company, and the 4th largest SBA 7(a) lender.

OPKO Health, Inc. is a medical test and medication company focused on diagnostics and pharmaceuticals. The company is a publicly traded company on NASDAQ and TASE under the symbol "OPK".

BY vs OPK — Head-to-Head

Bigger by revenue
OPK
OPK
1.3× larger
OPK
$148.5M
$112.4M
BY
Growing faster (revenue YoY)
BY
BY
+28.2% gap
BY
9.0%
-19.2%
OPK
Higher net margin
BY
BY
54.5% more per $
BY
33.4%
-21.1%
OPK
Faster 2-yr revenue CAGR
BY
BY
Annualised
BY
6.4%
-7.5%
OPK

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
BY
BY
OPK
OPK
Revenue
$112.4M
$148.5M
Net Profit
$37.6M
$-31.3M
Gross Margin
43.1%
Operating Margin
-25.8%
Net Margin
33.4%
-21.1%
Revenue YoY
9.0%
-19.2%
Net Profit YoY
33.0%
-322.8%
EPS (diluted)
$0.83
$-0.04

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BY
BY
OPK
OPK
Q1 26
$112.4M
Q4 25
$117.0M
$148.5M
Q3 25
$115.7M
$151.7M
Q2 25
$110.5M
$156.8M
Q1 25
$103.1M
$150.0M
Q4 24
$104.7M
$183.6M
Q3 24
$101.8M
$173.6M
Q2 24
$99.4M
$182.2M
Net Profit
BY
BY
OPK
OPK
Q1 26
$37.6M
Q4 25
$34.5M
$-31.3M
Q3 25
$37.2M
$21.6M
Q2 25
$30.1M
$-148.4M
Q1 25
$28.2M
$-67.6M
Q4 24
$30.3M
$14.0M
Q3 24
$30.3M
$24.9M
Q2 24
$29.7M
$-10.3M
Gross Margin
BY
BY
OPK
OPK
Q1 26
Q4 25
43.1%
Q3 25
32.9%
Q2 25
31.5%
Q1 25
28.4%
Q4 24
46.1%
Q3 24
23.1%
Q2 24
28.4%
Operating Margin
BY
BY
OPK
OPK
Q1 26
Q4 25
40.1%
-25.8%
Q3 25
43.1%
31.7%
Q2 25
35.2%
-38.3%
Q1 25
36.4%
-44.8%
Q4 24
38.6%
-18.0%
Q3 24
39.3%
8.2%
Q2 24
40.4%
-33.9%
Net Margin
BY
BY
OPK
OPK
Q1 26
33.4%
Q4 25
34.1%
-21.1%
Q3 25
32.1%
14.3%
Q2 25
27.2%
-94.7%
Q1 25
27.4%
-45.1%
Q4 24
34.3%
7.6%
Q3 24
29.8%
14.3%
Q2 24
29.9%
-5.7%
EPS (diluted)
BY
BY
OPK
OPK
Q1 26
$0.83
Q4 25
$0.77
$-0.04
Q3 25
$0.82
$0.03
Q2 25
$0.66
$-0.19
Q1 25
$0.64
$-0.10
Q4 24
$0.68
$0.02
Q3 24
$0.69
$0.03
Q2 24
$0.68
$-0.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BY
BY
OPK
OPK
Cash + ST InvestmentsLiquidity on hand
$198.4M
$364.4M
Total DebtLower is stronger
$344.0M
Stockholders' EquityBook value
$1.3B
$1.3B
Total Assets
$9.9B
$1.9B
Debt / EquityLower = less leverage
0.27×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BY
BY
OPK
OPK
Q1 26
$198.4M
Q4 25
$149.1M
$364.4M
Q3 25
$259.0M
$412.0M
Q2 25
$218.3M
$267.3M
Q1 25
$421.3M
$428.8M
Q4 24
$563.1M
$426.6M
Q3 24
$452.6M
$400.1M
Q2 24
$730.5M
$40.6M
Total Debt
BY
BY
OPK
OPK
Q1 26
Q4 25
$344.0M
Q3 25
$344.2M
Q2 25
$343.3M
Q1 25
$439.2M
Q4 24
$437.2M
Q3 24
$441.0M
Q2 24
$201.9M
Stockholders' Equity
BY
BY
OPK
OPK
Q1 26
$1.3B
Q4 25
$1.3B
$1.3B
Q3 25
$1.2B
$1.3B
Q2 25
$1.2B
$1.3B
Q1 25
$1.1B
$1.3B
Q4 24
$1.1B
$1.4B
Q3 24
$1.1B
$1.4B
Q2 24
$1.0B
$1.4B
Total Assets
BY
BY
OPK
OPK
Q1 26
$9.9B
Q4 25
$9.7B
$1.9B
Q3 25
$9.8B
$2.0B
Q2 25
$9.7B
$2.0B
Q1 25
$9.6B
$2.1B
Q4 24
$9.5B
$2.2B
Q3 24
$9.4B
$2.3B
Q2 24
$9.6B
$2.0B
Debt / Equity
BY
BY
OPK
OPK
Q1 26
Q4 25
0.27×
Q3 25
0.26×
Q2 25
0.26×
Q1 25
0.33×
Q4 24
0.32×
Q3 24
0.31×
Q2 24
0.14×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BY
BY
OPK
OPK
Operating Cash FlowLast quarter
$-25.9M
Free Cash FlowOCF − Capex
$-28.6M
FCF MarginFCF / Revenue
-19.3%
Capex IntensityCapex / Revenue
1.8%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-190.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BY
BY
OPK
OPK
Q1 26
Q4 25
$140.3M
$-25.9M
Q3 25
$38.3M
$-34.6M
Q2 25
$16.3M
$-83.4M
Q1 25
$27.1M
$-34.6M
Q4 24
$175.2M
$-44.4M
Q3 24
$19.8M
$-77.1M
Q2 24
$40.1M
$-26.4M
Free Cash Flow
BY
BY
OPK
OPK
Q1 26
Q4 25
$136.3M
$-28.6M
Q3 25
$38.0M
$-37.8M
Q2 25
$15.2M
$-86.7M
Q1 25
$25.0M
$-37.7M
Q4 24
$171.2M
$-49.8M
Q3 24
$19.1M
$-85.0M
Q2 24
$39.4M
$-33.7M
FCF Margin
BY
BY
OPK
OPK
Q1 26
Q4 25
116.5%
-19.3%
Q3 25
32.8%
-24.9%
Q2 25
13.7%
-55.3%
Q1 25
24.3%
-25.2%
Q4 24
163.5%
-27.1%
Q3 24
18.8%
-49.0%
Q2 24
39.7%
-18.5%
Capex Intensity
BY
BY
OPK
OPK
Q1 26
Q4 25
3.4%
1.8%
Q3 25
0.3%
2.1%
Q2 25
1.0%
2.1%
Q1 25
2.0%
2.1%
Q4 24
3.8%
2.9%
Q3 24
0.6%
4.6%
Q2 24
0.7%
4.0%
Cash Conversion
BY
BY
OPK
OPK
Q1 26
Q4 25
4.06×
Q3 25
1.03×
-1.60×
Q2 25
0.54×
Q1 25
0.96×
Q4 24
5.78×
-3.17×
Q3 24
0.65×
-3.10×
Q2 24
1.35×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BY
BY

Segment breakdown not available.

OPK
OPK

Services$71.1M48%
Transfer Of Intellectual Property And Other$33.7M23%
IE$22.1M15%
Rayaldee$8.8M6%
Barda Agreement$6.8M5%
MX$6.3M4%

Related Comparisons